SHSun-Il Hwang

Sun-Il Hwang

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Sun-Il Hwang has a total of 134 co-authors. Here are the top co-authors by number of shared publications:

  • David K. Han

    Department of Cell Biology and Center for Vascular Biology, University of Connecticut Health Center, Farmington, Connecticut, United States of America

    9 shared publications
  • Kimberly Q. McKinney

    Proteomics Laboratory for Clinical and Translational Research, Carolinas HealthCare System, Charlotte, North Carolina, United States of America

    7 shared publications
  • Deborah H. Lundgren

    Department of Cell Biology and Center for Vascular Biology, University of Connecticut Health Center, Farmington, CT

    5 shared publications
  • Herbert L. Bonkovsky

    The Liver-Biliary-Pancreatic Center, Carolinas HealthCare System, Charlotte, NC, USA

    5 shared publications
  • Jin-Gyun Lee

    Proteomics Laboratory for Clinical and Translational Research, Carolinas HealthCare System, Charlotte, North Carolina, United States of America

    5 shared publications
  • Yong-Yook Lee

    Proteomics Laboratory for Clinical and Translational Research, Carolinas HealthCare System, Charlotte, North Carolina, United States of America

    5 shared publications

Latest Publications

  • Homeostasis of iron and hepcidin in erythropoietic protoporphyria

    by Krista Bossi, Jingyun Lee, Paul Schmeltzer, Eric Holburton, Gale Groseclose, Siddesh Besur, Sunil Hwang, Herbert L. Bonkovsky

    Background: Erythropoietic protoporphyria (EPP) and X‐linked protoporphyria (XLP) are genetic abnormalities of heme synthesis that result in excess production of protoporphyrin and that manifest as severe photosensitivity. These disorders are often associated with iron deficiency anaemia (IDA). Our aim was to determine whether hepcidin is increased in EPP/XLP patients, resulting in decreased enteral iron absorption and IDA.Material and methods: Eight subjects with EPP, one with XLP and nine controls had baseline blood and urine samples collected, and thereafter were given oral ferrous sulphate (660 mg). Post‐iron blood and urine samples were collected at 2, 4, 6 and 8 h. Blood counts, serum cytokines, ferritin and iron studies were analysed at baseline. Serum iron studies, serum and urine hepcidin, and erythropoietin (Epo) were analysed at baseline and subsequent time points.Results: At baseline, EPP–XLP subjects had lower mean blood haemoglobin (13·9/15·3 g/dL) and serum ferritin (31·6/115 ng/mL) than controls. Serum iron levels increased markedly in both cohorts. Mean serum and urine hepcidin levels were significantly lower in the EPP–XLP group at 4 and 8 h post‐iron (serum – 4 h, 3·79/26·6, 8 h, 5·79/34·6 nM; urine – 4 h, 0·85/2·50, 8 h, 1·44/6·63 nM/mM creatinine). Serum cytokines and Epo were normal and not different between groups.Conclusions: We conclude that serum and urine hepcidin are not inappropriately increased in EPP/XLP subjects at baseline and do not increase over time as serum iron increases after oral ferrous sulphate. Levels of serum cytokines and Epo are normal in EPP/XLP. The molecular basis for the iron‐deficient phenotype in EPP/XLP remains unknown.


  • Open Access

    A Draft Map of Rhesus Monkey Tissue Proteome for Biomedical Research

    by Jin-Gyun Lee, Kimberly Q. McKinney, Yong-Yook Lee, Hae-Na Chung, Antonis J. Pavlopoulos, Kook Y. Jung, Woong-Ki Kim, Marcelo J. Kuroda, David K. Han, Sunil Hwang

    Though the rhesus monkey is one of the most valuable non-human primate animal models for various human diseases because of its manageable size and genetic and proteomic similarities with humans, proteomic research using rhesus monkeys still remains challenging due to the lack of a complete protein sequence database and effective strategy. To investigate the most effective and high-throughput proteomic strategy, comparative data analysis was performed employing various protein databases and search engines. The UniProt databases of monkey, human, bovine, rat and mouse were used for the comparative analysis and also a universal database with all protein sequences from all available species was tested. At the same time, de novo sequencing was compared to the SEQUEST search algorithm to identify an optimal work flow for monkey proteomics. Employing the most effective strategy, proteomic profiling of monkey organs identified 3,481 proteins at 0.5% FDR from 9 male and 10 female tissues in an automated, high-throughput manner. Data are available via ProteomeXchange with identifier PXD001972. Based on the success of this alternative interpretation of MS data, the list of proteins identified from 12 organs of male and female subjects will benefit future rhesus monkey proteome research.


  • Identification of anti-metastatic drug and natural compound targets in isogenic colorectal cancer cells

    by Jin-Gyun Lee, Kimberly Q. McKinney, Antonis J. Pavlopoulos, Jeong-Hill Park, Sunil Hwang


  • Open Access

    Data supporting the identification of anti-metastatic drug and natural compound targets in isogenic colorectal cancer cells

    by Jin-Gyun Lee, Kimberly Q. McKinney, Antonis J. Pavlopoulos, Jeong-Hill Park, Sunil Hwang


  • Open Access

    Cellular Proteins Associated with the Interior and Exterior of Vesicular Stomatitis Virus Virions

    by Megan Moerdyk-Schauwecker, Sun-Il Hwang, Valery Z. Grdzelishvili

    Virus particles (virions) often contain not only virus-encoded but also host-encoded proteins. Some of these host proteins are enclosed within the virion structure, while others, in the case of enveloped viruses, are embedded in the host-derived membrane. While many of these host protein incorporations are likely accidental, some may play a role in virus infectivity, replication and/or immunoreactivity in the next host. Host protein incorporations may be especially important in therapeutic applications where large numbers of virus particles are administered. Vesicular stomatitis virus (VSV) is the prototypic rhabdovirus and a candidate vaccine, gene therapy and oncolytic vector. Using mass spectrometry, we previously examined cell type dependent host protein content of VSV virions using intact (“whole”) virions purified from three cell lines originating from different species. Here we aimed to determine the localization of host proteins within the VSV virions by analyzing: i) whole VSV virions; and ii) whole VSV virions treated with Proteinase K to remove all proteins outside the viral envelope. A total of 257 proteins were identified, with 181 identified in whole virions and 183 identified in Proteinase K treated virions. Most of these proteins have not been previously shown to be associated with VSV. Functional enrichment analysis indicated the most overrepresented categories were proteins associated with vesicles, vesicle-mediated transport and protein localization. Using western blotting, the presence of several host proteins, including some not previously shown in association with VSV (such as Yes1, Prl1 and Ddx3y), was confirmed and their relative quantities in various virion fractions determined. Our study provides a valuable inventory of virion-associated host proteins for further investigation of their roles in the replication cycle, pathogenesis and immunoreactivity of VSV.


  • Proteomic strategy for probing complementary lethality of kinase inhibitors against pancreatic cancer

    by Jin‐Gyun Lee, Kimberly Q. McKinney, Jean‐Luc Mougeot, Herbert L. Bonkovsky, Sun‐Il Hwang

    In the present study, proteomic analysis was performed to discover combinational molecular targets for therapy and chemoresistance by comparing differential protein expression from Panc‐1 cells treated with FDA‐approved drugs such as sunitinib, imatinib mesylate, dasatinib, and PD184352. A total of 4041 proteins were identified in the combined data from all of the treatment groups by nano‐electrospray ultra‐performance LC and MS/MS analysis. Most of the proteins with significant changes are involved in apoptosis, cytoskeletal remodeling, and epithelial‐to‐mesenchymal transition. These processes are associated with increased chemoresistance and progression of pancreatic cancer. Among the differentially expressed proteins, heme oxygenase‐1 (HO‐1) was found in the sunitinib and imatinib mesylate treatment groups, which possibly acts as a specific target for synthetic lethality in combinational treatment. HO‐1 was found to play a key role in sensitizing the chemoresistant Panc‐1 cell line to drug therapy. Viability was significantly decreased in Panc‐1 cells cotreated with sunitinib and imatinib mesylate at low doses, compared to those treated with sunitinib or imatinib mesylate alone. The results suggest that induction of chemosensitization by manipulating specific molecular targets can potentiate synergistic chemotherapeutic effects at lower, better tolerated doses, and in turn reduce the toxicity of multidrug treatment of pancreatic cancer.


  • Catechins in Dietary Supplements and Hepatotoxicity

    by Victor J. Navarro, Herbert L. Bonkovsky, Sun-Il Hwang, Maricruz Vega, Huiman Barnhart, Jose Serrano

    Many herbal dietary supplements (HDS) contain green tea extract (GTE) and its component catechins, although their presence may not always be indicated on the product label.


  • Open Access

    Circadian rhythms in acute intermittent porphyria – a pilot study

    by Sebastian Larion, Frederick R. Caballes, Sun‐Il Hwang, Jin‐Gyun Lee, Whitney E. Rossman, Judy Parsons, Nury Steuerwald, Ting Li, Vinaya Maddukuri, Gale Groseclose, et al.

    Background: Acute intermittent porphyria (AIP) is an inherited disorder of haem synthesis wherein a partial deficiency of porphobilinogen (PBG) deaminase (PBGD) with other factors may give rise to biochemical and clinical manifestations of disease. The biochemical hallmarks of activeAIPare relative hepatic haem deficiency and uncontrolled up‐regulation of hepatic 5‐aminolevulinic acid (ALA) synthase‐1 (ALAS1) with over‐production ofALAandPBG. The treatment of choice is intravenous haem, which restores the deficient regulatory haem pool of the liver and repressesALAS1. Recently, haem has been shown to influence circadian rhythms by controlling their negative feedback loops. We evaluated whether subjects withAIPexhibited an altered circadian profile.Materials and methods: Over a 21‐h period, we measured levels of serum cortisol, melatonin,ALA,PBGand mRNAlevels (in peripheral blood mononuclear cells) of selected clock‐controlled genes and genes involved in haem synthesis in 10Caucasian (European‐American) women who were either postmenopausal or had been receiving female hormone therapy, six of whom haveAIPand four do not and are considered controls.Results: FourAIPsubjects with biochemical activity exhibited higher levels ofPBGand lower levels and dampened oscillation of serum cortisol, and a trend for lower levels of serum melatonin, than controls orAIPsubjects without biochemical activity. Levels of clock‐controlled gene mRNAs showed significant increases over baseline in all subjects at 5 a.m. and 11 p.m., whereas mRNA levels ofALAS1,ALAS2 andPBGDwere increased only at 11 p.m. in subjects with activeAIP.Conclusions: This pilot study provides evidence for disturbances of circadian markers in women with activeAIPthat may trigger or sustain some common clinical features ofAIP.


    • 20 September 2012
      • Vol. 9  (5) , 257-63

    Identification of differentially expressed proteins from primary versus metastatic pancreatic cancer cells using subcellular proteomics.

    by Kimberly Q McKinney, Jin-Gyun Lee, David Sindram, Mark W Russo, David K Han, Herbert L Bonkovsky, Sunil Hwang

    Pancreatic cancer is an aggressive disease with nearly equal yearly rates of diagnosis and death. Current therapies have failed to improve outcomes due to rapid disease progression and late stage at presentation. Recently, pathways involved in progression and metastasis have been elucidated; however, new knowledge has not generated more effective therapies. We report on the use of subcellular fractionation and liquid chromatography (LC)-mass spectrometry to identify 3,907 proteins in four pancreatic cancer cell lines, 540 of which are unique to primary cancer cells, and 487 unique to cells derived from metastatic sites. Statistical analysis identified 134 proteins significantly differentially expressed between the two populations. The subcellular localization of these proteins was determined and expression levels for four targets were validated using western blot techniques. These identified proteins can be further investigated to determine their roles in progression and metastasis and may serve as therapeutic targets in the development of more effective treatments for pancreatic cancer.